Showing results (171-180 of 213) with videos related to
Sort By:
Pageof 22
Theranostics|October 8, 2019
Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-conceptAurélie Rondon, Sébastien Schmitt, Arnaud Briat, et al.Nuclear Medicine and Biology|May 20, 2023
Synthesis and preclinical evaluation of two osimertinib isotopologues labeled with carbon-11 as PET tracers targeting the tyrosine kinase domain of the epidermal growth factor receptorAntonia Högnäsbacka, Alex J Poot, Esther Kooijman, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 26, 2026
Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric CancerPaul C Klauser, Gina Dehlavi, Michele De Franco, et al.ACS Chemical Neuroscience|August 26, 2017
Pharmacological Evaluation of Novel Bioisosteres of an Adamantanyl Benzamide P2X7 Receptor AntagonistShane M Wilkinson, Melissa L Barron, James O'Brien-Brown, et al.Theranostics|October 24, 2022
Advancing 89Zr-immuno-PET in neuroscience with a bispecific anti-amyloid-beta monoclonal antibody - The choice of chelator is essentialThomas E Wuensche, Natascha Stergiou, Iris Mes, et al.Journal of Medical Virology|October 14, 2024
Imaging the immune sequelae of infection with SARS-CoV-2 in nonhuman primates by using two nanobody PET-tracersGerrit Koopman, Tom Verhoeven, Petra Mooij, et al.Journal of Materials Chemistry. B|December 28, 2020
Pre-targeting with ultra-small nanoparticles: boron carbon dots as drug candidates for boron neutron capture therapyIrene V J Feiner, Krishna R Pulagam, Kepa B Uribe, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 28, 2022
CD133 as a Biomarker for an Autoantibody-to-ImmunoPET Paradigm for the Early Detection of Small Cell Lung CancerAndrew G Kunihiro, Samantha M Sarrett, Kristin J Lastwika, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2020
Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical 89Zr-immuno-PETMarion Chomet, Maxime Schreurs, Maria J Bolijn, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 21, 2013
Multicenter harmonization of 89Zr PET/CT performanceNikolaos E Makris, Ronald Boellaard, Eric P Visser, et al.Pageof 22